Lv6
1620 积分 2024-10-12 加入
IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation
1个月前
已完结
Pediatric Acute Lymphoblastic Leukemia With Hypereosinophilia and IDH2 Gene Mutation: A Case Report and Literature Review
9个月前
已关闭
IDH1 mutation in acute lymphoblastic leukemia—A rare but significant finding
9个月前
已完结
Resistance to mutant IDH inhibitors in acute myeloid leukemia: Molecular mechanisms and therapeutic strategies
10个月前
已完结
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial
10个月前
已完结
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges
10个月前
已完结
AML treatment: conventional chemotherapy and emerging novel agents
10个月前
已完结
Current status of phase 3 clinical trials in high-risk myelodysplastic syndromes: pitfalls and recommendations
1年前
已完结
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study
1年前
已完结
皖公网安备34019202002308
